BAH earned $851M on $11.2B revenue in FY2026 — a 9% earnings decline on a 6.4% revenue decline. Cost-cutting preserved margins. The National Security segment ($38B backlog, $53B pipeline) is the offset to the Civil damage. At 11.5x trailing PE with 8.2% FCF yield and a 2.97% dividend, the stock is optically cheap. Goldman Sachs downgraded to Sell in May 2025 forecasting flat revenue through 2028. The market is divided: 13 analysts range $74-$160 with $93.77 mean. Short interest at 7.39% is elevated for a defense contractor. The critical unknown is whether Civil stabilizes by H2 FY2027.
Key Metrics
Thesis
A tale of two businesses. National Security (~66% of revenue) is healthy — $38B backlog, mid-single-digit growth, major contract wins in missile defense and AI. Civil (~32%) structurally damaged by DOGE — contracts cancelled, layoffs, FY27 guidance for further decline. At $79.48 the stock is cheap enough to compensate for uncertainty IF Civil stabilizes. But confidence is LOW — the central question can't be answered with available evidence. Q1 FY2027 earnings (~July 24) is the critical catalyst.
Research Memo
DOGE Structurally Damaged the Civil Segment
Civil revenue fell 20-28% in FY2026. 60-68 contracts cancelled representing $600M+. 31 Treasury contracts terminated (tied to tax leak scandal). ~2,500-3,000 layoffs concentrated in Civil. FY27 guidance calls for another high-single-digit decline before possible H2 stabilization. This is not a cyclical headwind — it's a structural impairment of the federal consulting model.
National Security Is the Offset
$38B total backlog (+3% YoY), $53B pipeline (+12% YoY), mid-single-digit growth expected. Major wins: BEATS ($937M Army), DIA WAEDS ($1.58B intelligence), Air Force app modernization ($743M), Army MCTP ($697M). Q4 alone saw $1.7B in national security contract awards.
Valuation Is Cheap But the 'E' Is Uncertain
At 11.5x trailing PE and 11.6x forward PE, BAH is priced for continued earnings decline. The 8.2% FCF yield (on market cap) and 2.97% dividend yield provide a floor. But the P/E multiple is only 'cheap' if earnings don't fall further. The bull case: Civil stabilizes at 20-25% of revenue and BAH becomes a higher-margin defense pure-play.
Short Interest Creates Asymmetric Upside
Short interest at 7.39% of float with 5.36 days to cover is elevated for a defense contractor (typically 2-4%). Any positive catalyst — Civil stabilization, better-than-feared guidance, major contract win — could trigger covering. But shorts may be right. The setup is 'elevated short interest on a cheap stock with a catalyst date,' not 'imminent squeeze.'
QA Evaluation
- Confidence DOWNGRADED from Medium to Low — the central thesis question cannot be answered with available evidence
- Critical gap: no peer comparison (CACI, SAIC, LDOS) to distinguish BAH-specific from sector-wide issues
- FCF yield should show both market cap (8.2%) and EV (6.1%) denominators
- ROE of 80.7% is leverage-distorted — ROA (9.5%) is the honest metric
- Goldman downgrade is 13 months old — current rating unknown
- The 'squeeze' language overstates: 7.39% short float is elevated but not squeeze territory
Timeline
Risks
Open Questions
- Will Civil stabilize by H2 FY2027? Q1 FY2027 earnings (July 24) will provide first evidence
- What is Goldman's CURRENT rating? The May 2025 Sell is 13 months old
- How do peers (CACI, SAIC, LDOS) compare — is BAH's decline company-specific or sector-wide?
- Is the $38B backlog 'real' revenue or mostly unexercised option years and IDIQ ceilings?
Review Triggers
- Q1 FY2027 earnings (~July 24, 2026) — Civil stabilization test
- Any major DOGE policy announcement affecting federal procurement
- BAH crosses above $85 (break above recent range) or below $74 (analyst low)
Agent Notes
Peer comparison gap is critical — without CACI/SAIC/LDOS, we can't distinguish company-specific from sector-wide issues. Backlog figure ($38B) includes unexercised options — need 10-K to determine obligated vs. ceiling values. Short interest elevated but not squeeze territory. Key catalyst is July 24 earnings.